402 related articles for article (PubMed ID: 21355879)
1. Melatonin treatment restores mitochondrial function in Alzheimer's mice: a mitochondrial protective role of melatonin membrane receptor signaling.
Dragicevic N; Copes N; O'Neal-Moffitt G; Jin J; Buzzeo R; Mamcarz M; Tan J; Cao C; Olcese JM; Arendash GW; Bradshaw PC
J Pineal Res; 2011 Aug; 51(1):75-86. PubMed ID: 21355879
[TBL] [Abstract][Full Text] [Related]
2. Caffeine increases mitochondrial function and blocks melatonin signaling to mitochondria in Alzheimer's mice and cells.
Dragicevic N; Delic V; Cao C; Copes N; Lin X; Mamcarz M; Wang L; Arendash GW; Bradshaw PC
Neuropharmacology; 2012 Dec; 63(8):1368-79. PubMed ID: 22959965
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice.
Dragicevic N; Mamcarz M; Zhu Y; Buzzeo R; Tan J; Arendash GW; Bradshaw PC
J Alzheimers Dis; 2010; 20 Suppl 2():S535-50. PubMed ID: 20463404
[TBL] [Abstract][Full Text] [Related]
4. Green tea epigallocatechin-3-gallate (EGCG) and other flavonoids reduce Alzheimer's amyloid-induced mitochondrial dysfunction.
Dragicevic N; Smith A; Lin X; Yuan F; Copes N; Delic V; Tan J; Cao C; Shytle RD; Bradshaw PC
J Alzheimers Dis; 2011; 26(3):507-21. PubMed ID: 21694462
[TBL] [Abstract][Full Text] [Related]
5. Long-term electromagnetic field treatment enhances brain mitochondrial function of both Alzheimer's transgenic mice and normal mice: a mechanism for electromagnetic field-induced cognitive benefit?
Dragicevic N; Bradshaw PC; Mamcarz M; Lin X; Wang L; Cao C; Arendash GW
Neuroscience; 2011 Jun; 185():135-49. PubMed ID: 21514369
[TBL] [Abstract][Full Text] [Related]
6. Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer disease.
Olcese JM; Cao C; Mori T; Mamcarz MB; Maxwell A; Runfeldt MJ; Wang L; Zhang C; Lin X; Zhang G; Arendash GW
J Pineal Res; 2009 Aug; 47(1):82-96. PubMed ID: 19538338
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of melatonin on amyloid-beta peptide 25-35-induced mitochondrial dysfunction in hippocampal neurons at different stages of culture.
Dong W; Huang F; Fan W; Cheng S; Chen Y; Zhang W; Shi H; He H
J Pineal Res; 2010 Mar; 48(2):117-25. PubMed ID: 20041986
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial dysfunction: an early event in Alzheimer pathology accumulates with age in AD transgenic mice.
Hauptmann S; Scherping I; Dröse S; Brandt U; Schulz KL; Jendrach M; Leuner K; Eckert A; Müller WE
Neurobiol Aging; 2009 Oct; 30(10):1574-86. PubMed ID: 18295378
[TBL] [Abstract][Full Text] [Related]
9. Decreased accumulation of subcellular amyloid-β with improved mitochondrial function mediates the neuroprotective effect of huperzine A.
Yang L; Ye CY; Huang XT; Tang XC; Zhang HY
J Alzheimers Dis; 2012; 31(1):131-42. PubMed ID: 22531425
[TBL] [Abstract][Full Text] [Related]
10. Interaction between NH(2)-tau fragment and Aβ in Alzheimer's disease mitochondria contributes to the synaptic deterioration.
Amadoro G; Corsetti V; Atlante A; Florenzano F; Capsoni S; Bussani R; Mercanti D; Calissano P
Neurobiol Aging; 2012 Apr; 33(4):833.e1-25. PubMed ID: 21958963
[TBL] [Abstract][Full Text] [Related]
11. Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice.
Trinchese F; Liu S; Battaglia F; Walter S; Mathews PM; Arancio O
Ann Neurol; 2004 Jun; 55(6):801-14. PubMed ID: 15174014
[TBL] [Abstract][Full Text] [Related]
12. Amyloid precursor protein and amyloid beta-peptide bind to ATP synthase and regulate its activity at the surface of neural cells.
Schmidt C; Lepsverdize E; Chi SL; Das AM; Pizzo SV; Dityatev A; Schachner M
Mol Psychiatry; 2008 Oct; 13(10):953-69. PubMed ID: 17726461
[TBL] [Abstract][Full Text] [Related]
13. Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain beta-amyloid production.
Arendash GW; Schleif W; Rezai-Zadeh K; Jackson EK; Zacharia LC; Cracchiolo JR; Shippy D; Tan J
Neuroscience; 2006 Nov; 142(4):941-52. PubMed ID: 16938404
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial dysfunction in the APP/PSEN1 mouse model of Alzheimer's disease and a novel protective role for ascorbate.
Dixit S; Fessel JP; Harrison FE
Free Radic Biol Med; 2017 Nov; 112():515-523. PubMed ID: 28863942
[TBL] [Abstract][Full Text] [Related]
15. Early melatonin supplementation alleviates oxidative stress in a transgenic mouse model of Alzheimer's disease.
Feng Z; Qin C; Chang Y; Zhang JT
Free Radic Biol Med; 2006 Jan; 40(1):101-9. PubMed ID: 16337883
[TBL] [Abstract][Full Text] [Related]
16. Melatonin alleviates behavioral deficits associated with apoptosis and cholinergic system dysfunction in the APP 695 transgenic mouse model of Alzheimer's disease.
Feng Z; Chang Y; Cheng Y; Zhang BL; Qu ZW; Qin C; Zhang JT
J Pineal Res; 2004 Sep; 37(2):129-36. PubMed ID: 15298672
[TBL] [Abstract][Full Text] [Related]
17. Regional metabolic alteration of Alzheimer's disease in mouse brain expressing mutant human APP-PS1 by 1H HR-MAS.
Woo DC; Lee SH; Lee DW; Kim SY; Kim GY; Rhim HS; Choi CB; Kim HY; Lee CU; Choe BY
Behav Brain Res; 2010 Jul; 211(1):125-31. PubMed ID: 20307581
[TBL] [Abstract][Full Text] [Related]
18. Melatonin and its brain metabolite N(1)-acetyl-5-methoxykynuramine prevent mitochondrial nitric oxide synthase induction in parkinsonian mice.
Tapias V; Escames G; López LC; López A; Camacho E; Carrión MD; Entrena A; Gallo MA; Espinosa A; Acuña-Castroviejo D
J Neurosci Res; 2009 Oct; 87(13):3002-10. PubMed ID: 19437546
[TBL] [Abstract][Full Text] [Related]
19. Presenilin 1 regulates the processing of beta-amyloid precursor protein C-terminal fragments and the generation of amyloid beta-protein in endoplasmic reticulum and Golgi.
Xia W; Zhang J; Ostaszewski BL; Kimberly WT; Seubert P; Koo EH; Shen J; Selkoe DJ
Biochemistry; 1998 Nov; 37(47):16465-71. PubMed ID: 9843412
[TBL] [Abstract][Full Text] [Related]
20. Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1.
Ohno M; Chang L; Tseng W; Oakley H; Citron M; Klein WL; Vassar R; Disterhoft JF
Eur J Neurosci; 2006 Jan; 23(1):251-60. PubMed ID: 16420434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
